The roles of individual mammalian argonautes in RNA interference in vivo

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Ruda, Vera M ^a,d   Chandwani, Rohit ^c   Sehgal, Alfica ^b   Bogorad, Roman L ^a   Akinc, Akin ^b   Charisse, Klaus ^b   Tarakhovsky, Alexander ^c   Novobrantseva, Tatiana I ^b   Koteliansky, Victor ^a,e  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b ALNYLAM PHARMACEUTICALS   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^e SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 1 PROTEIN; ARGONAUTE 2 PROTEIN; ARGONAUTE 3 PROTEIN; ARGONAUTE PROTEIN; MESSENGER RNA; RAB PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; AGO3 PROTEIN, MOUSE; EIF2C1 PROTEIN, MOUSE; EIF2C2 PROTEIN, MOUSE; INITIATION FACTOR;

3' UNTRANSLATED REGION; AGO1 GENE; AGO2 GENE; AGO3 GENE; ANIMAL CELL; ARTICLE; CODING SEQUENCE; CONTROLLED STUDY; EMBRYO; GENE SEQUENCE; GENE SILENCING; GENE TARGETING; GENETIC CODE; IN VIVO STUDY; LIVER PARENCHYMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; RAB5C GENE; RNA CLEAVAGE; RNA INTERFERENCE; 3T3 CELL LINE; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; FEMALE; FIBROBLAST; GENETICS; LIVER; MAMMALIAN EMBRYO; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; ARGONAUTE PROTEINS; CELLS, CULTURED; EMBRYO, MAMMALIAN; EUKARYOTIC INITIATION FACTORS; FEMALE; FIBROBLASTS; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NIH 3T3 CELLS; RNA INTERFERENCE; RNA, MESSENGER;

EID: 84903790691     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101749     Document Type: Article

References (52)

1. Rettig GR, Behlke MA (2012) Progress toward in vivo use of siRNAs-II. Mol Ther 20: 483-512.
2. Castanotto D, Rossi JJ (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature 457: 426-433.
3. Ender C, Meister G (2010) Argonaute proteins at a glance. J Cell Sci 123: 1819-1823.
4. Djuranovic S, Nahvi A, Green R (2011) A parsimonious model for gene regulation by miRNAs. Science 331: 550-553.
5. Wang B, Li S, Qi HH, Chowdhury D, Shi Y, et al. (2009) Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins. Nat Struct Mol Biol 16: 1259-1266.
6. Gu S, Jin L, Zhang F, Huang Y, Grimm D, et al. (2011) Thermodynamic stability of small hairpin RNAs highly influences the loading process of different mammalian Argonautes. Proc Natl Acad Sci U S A 108: 9208-9213.
7. Wang HW, Noland C, Siridechadilok B, Taylor DW, Ma E, et al. (2009) Structural insights into RNA processing by the human RISC-loading complex. Nat Struct Mol Biol 16: 1148-1153.
8. Elkayam E, Kuhn CD, Tocilj A, Haase AD, Greene EM, et al. (2012) The structure of human argonaute-2 in complex with miR-20a. Cell 150: 100-110.
9. Nakanishi K, Weinberg DE, Bartel DP, Patel DJ (2012) Structure of yeast Argonaute with guide RNA. Nature 486: 368-374.
10. Schirle NT, MacRae IJ (2012) The crystal structure of human Argonaute2. Science 336: 1037-1040.
11. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, et al. (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science 305: 1437-1441. (Pubitemid 39167657)
12. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, et al. (2004) Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 15: 185-197. (Pubitemid 38950966)
13. Grimm D, Wang L, Lee JS, Schürmann N, Gu S, et al. (2010) Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. J Clin Invest 120: 3106-3119.
14. Vickers TA, Lima WF, Wu H, Nichols JG, Linsley PS, et al. (2009) Off-target and a portion of target-specific siRNA mediated mRNA degradation is Ago2 'Slicer' independent and can be mediated by Ago1. Nucleic Acids Res 37: 6927-6941.
15. Broderick JA, Zamore PD (2011) MicroRNA therapeutics. Gene Ther 18: 1104-1110.
16. Burroughs AM, Ando Y, de Hoon MJ, Tomaru Y, Suzuki H, et al. (2011) Deepsequencing of human Argonaute-associated small RNAs provides insight into miRNA sorting and reveals Argonaute association with RNA fragments of diverse origin. RNA Biol 8: 158-177.
17. Czech B, Hannon GJ (2011) Small RNA sorting: matchmaking for Argonautes. Nat Rev Genet 12: 19-31.
18. Landthaler M, Gaidatzis D, Rothballer A, Chen PY, Soll SJ, et al. (2008) Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. RNA 14: 2580-2596.
19. Meister G, Landthaler M, Peters L, Chen PY, Urlaub H, et al. (2005) Identification of novel argonaute-associated proteins. Curr Biol 15: 2149-2155. (Pubitemid 41739749)
20. Fabian MR, Mathonnet G, Sundermeier T, Mathys H, Zipprich JT, et al. (2009) Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. Mol Cell 35: 868-880.
21. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515-524. (Pubitemid 43345317)
22. Wu L, Belasco JG (2008) Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell 29: 1-7.
23. Doench JG, Petersen CP, Sharp PA (2003) siRNAs can function as miRNAs. Genes Dev 17: 438-442. (Pubitemid 36258757)
24. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114.
25. Nishihara T, Zekri L, Braun JE, Izaurralde E (2013) miRISC recruits decapping factors to miRNA targets to enhance their degradation. Nucleic Acids Res.
26. Djuranovic S, Nahvi A, Green R (2012) miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 336: 237-240.
27. Wu L, Fan J, Belasco JG (2008) Importance of translation and nonnucleolytic ago proteins for on-target RNA interference. Curr Biol 18: 1327-1332.
28. Cenik ES, Zamore PD (2011) Argonaute proteins. Curr Biol 21: R446-449.
29. Haussecker D, Huang Y, Lau A, Parameswaran P, Fire AZ, et al. (2010) Human tRNA-derived small RNAs in the global regulation of RNA silencing. RNA 16: 673-695.
30. Su H, Trombly MI, Chen J, Wang X (2009) Essential and overlapping functions for mammalian Argonautes in microRNA silencing. Genes Dev 23: 304-317.
31. O'Carroll D, Mecklenbrauker I, Das PP, Santana A, Koenig U, et al. (2007) A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev 21: 1999-2004. (Pubitemid 47267286)
32. Gu S, Jin L, Zhang F, Sarnow P, Kay MA (2009) Biological basis for restriction of microRNA targets to the 39 untranslated region in mammalian mRNAs. Nat Struct Mol Biol 16: 144-150.
33. Janowski BA, Huffman KE, Schwartz JC, Ram R, Nordsell R, et al. (2006) Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat Struct Mol Biol 13: 787-792. (Pubitemid 44338772)
34. Bartlett DW, Davis ME (2006) Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Res 34: 322-333. (Pubitemid 43160055)
35. Peters L, Meister G (2007) Argonaute proteins: mediators of RNA silencing. Mol Cell 26: 611-623. (Pubitemid 46856239)
36. Forman JJ, Legesse-Miller A, Coller HA (2008) A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A 105: 14879-14884.
37. Mescalchin A, Detzer A, Weirauch U, Hahnel MJ, Engel C, et al. (2010) Antisense tools for functional studies of human Argonaute proteins. RNA 16: 2529-2536.
38. John M, Constien R, Akinc A, Goldberg M, Moon YA, et al. (2007) Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway. Nature 449: 745-747. (Pubitemid 47552094)
39. Akinc A, Querbes W, De S, Qin J, Frank-Kamenetsky M, et al. (2010) Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol Ther 18: 1357-1364.
40. Jayaraman M, Ansell SM, Mui BL, Tam YK, Chen J, et al. (2012) Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew Chem Int Ed Engl 51: 8529-8533.
41. Adams BD, Claffey KP, White BA (2009) Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells. Endocrinology 150: 14-23.
42. De N, Young L, Lau PW, Meisner NC, Morrissey DV, et al. (2013) Highly Complementary Target RNAs Promote Release of Guide RNAs from Human Argonaute2. Mol Cell 50: 344-355.
43. Kaelin WG (2012) Molecular biology. Use and abuse of RNAi to study mammalian gene function. Science 337: 421-422.
44. Wang D, Zhang Z, O'Loughlin E, Lee T, Houel S, et al. (2012) Quantitative functions of Argonaute proteins in mammalian development. Genes Dev 26: 693-704.
45. Shi H, Tschudi C, Ullu E (2007) Depletion of newly synthesized Argonaute1 impairs the RNAi response in Trypanosoma brucei. RNA 13: 1132-1139. (Pubitemid 46984902)
46. Olejniczak SH, La Rocca G, Gruber JJ, Thompson CB (2013) Long-lived microRNA-Argonaute complexes in quiescent cells can be activated to regulate mitogenic responses. Proc Natl Acad Sci U S A 110: 157-162.
47. Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, Busini V, et al. (2008) A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol 26: 561-569. (Pubitemid 351668042)
48. Love KT, Mahon KP, Levins CG, Whitehead KA, Querbes W, et al. (2010) Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci U S A 107: 1864-1869.
49. Zeigerer A, Gilleron J, Bogorad RL, Marsico G, Nonaka H, et al. (2012) Rab5 is necessary for the biogenesis of the endolysosomal system in vivo. Nature 485: 465-470.
50. Akinc A, Goldberg M, Qin J, Dorkin JR, Gamba-Vitalo C, et al. (2009) Development of lipidoid-siRNA formulations for systemic delivery to the liver. Mol Ther 17: 872-879.
51. Semple SC, Akinc A, Chen J, Sandhu AP, Mui BL, et al. (2010) Rational design of cationic lipids for siRNA delivery. Nat Biotechnol 28: 172-176.
52. Foster DJ, Barros S, Duncan R, Shaikh S, Cantley W, et al. (2012) Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo. RNA 18: 557-568.